cefepime-taniborbactam [Antibiotic+Adjuvant]

Accession ARO:3007148
DefinitionAn antibiotic cocktail containing the beta-lactam antibiotic cefepime and the beta-lactamase inhibitor taniborbactam. As of 2022, this antibiotic-adjuvant mixture is in phase III clinical trials for the treatment of various bacterial infections.
Drug Classcephalosporin
Classification12 ontology terms | Show
Parent Term(s)3 ontology terms | Show
+ antibiotic mixture
+ has_part taniborbactam [Adjuvant]
+ has_part cefepime [Antibiotic]
Sub-Term(s)
1 ontology terms | Show
+ NDM-9 confers_resistance_to_antibiotic
Publications

Hamrick JC, et al. 2020. Antimicrob Agents Chemother 64(3): VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa. (PMID 31871094)